Characterization of the aryl hydrocarbon receptor as a potential candidate to improve cancer T cell therapies. - De Castro V; Abdellaoui O; Dehecq B; Ndao B; Mercier-Letondal P; Dauvé A; Garnache-Ottou F; Adotévi O; Loyon R; Godet Y (Cancer immunology, immunotherapy : CII, 2025)